Dougherty Initiates Coverage on Phase Forward (PFWD) with a Buy

July 18, 2008 7:37 AM EDT

Dougherty initiates coverage on Phase Forward (Nasdaq: PFWD) with a Buy. Price target $22.50.

Phase Forward Incorporated is a provider of integrated enterprise-level software products, services and hosted solutions for use in the global clinical trial and drug safety monitoring activities of its customers.


Related Categories

New Coverage

Stocks Mentioned

PFWD 10.32

+0.58 +5.95%
Volume: 834,601
Track PFWD


Add Your Comment